Summer is well and truly over and it’s time to get back to work. What better way than by expanding your library with some key reading matter?
— by John Carreyrou
John Carreyrou serves up the inside story on the collapse of Theranos, a multi-billion-dollar biotech start-up which developed a machine that would make blood-testing faster and easier. An initial fundraising round valued the company at $9bn, and the wealth of founder Elizabeth Holmes at $4.7bn. The only problem: the tech didn’t work. While the title fails to mention governance, Theranos was in essence a governance failure of epic proportions. A lesson for all those rushing to ride the next “unicorn” that comes along.
Corporate Governance and Value Creation in Japan
— by Ryohei Yanaga
For thoughtful journalism, expert insights on corporate governance and an extensive library of reports, guides and tools to help boards and directors navigate the complexities of their roles, subscribe to Board Agenda